{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:36:48Z","timestamp":1790537808799,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Treatment of catheter-related bloodstream infections (CRBSI) is hampered by the characteristic tolerance of bacterial biofilms towards antibiotics. Our objective was to study the effect of the combination of antibiotics and the alkaline amino acid l-arginine or the cation chelator EDTA on the bacterial killing of in vitro biofilms formed by an array of clinical strains responsible for CRBSI and representative of epidemiologically relevant bacterial species.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Among 32 strains described in a previous clinical study, we focused on the most antibiotic-tolerant strains including CoNS (n\u200a=\u200a4), Staphylococcus aureus (n\u200a=\u200a4), Enterococcus faecalis (n\u200a=\u200a2), Pseudomonas aeruginosa (n\u200a=\u200a4) and Enterobacteriaceae (n\u200a=\u200a4). We used an in vitro biofilm model (96-well plate assay) to study biofilm tolerance and tested various combinations of antibiotics and non-antibiotic adjuvants. Gentamicin, amikacin or vancomycin was combined with disodium EDTA or l-arginine for 24 h to reproduce the antibiotic lock therapy (ALT) approach. Killing of biofilm bacteria was measured by cfu quantification after a vigorous step of pipetting up and down in order to detach all biofilm bacteria from the surface of the wells.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Both of our adjuvant strategies significantly increased the effect of antibiotics against biofilms formed by Gram-positive and Gram-negative bacterial pathogens. The combination of gentamicin\u200a+\u200aEDTA was active against all tested strains apart from one P. aeruginosa. The combination of gentamicin\u200a+\u200al-arginine was active against most of the tested strains with the notable exception of CoNS for which no potentiation was observed. We also demonstrated that amikacin\u200a+\u200aEDTA was active against Gram-negative bacteria and that vancomycin\u200a+\u200aEDTA was active against Gram-positive bacteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The addition of EDTA enhanced the activity of gentamicin, amikacin and vancomycin against biofilms formed by a wide spectrum of bacterial strains responsible for CRBSI.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkv044","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T01:31:20Z","timestamp":1425519080000},"page":"1704-1712","source":"Crossref","is-referenced-by-count":55,"title":["<i>In vitro<\/i> activity of gentamicin, vancomycin or amikacin combined with EDTA or <scp>l<\/scp>-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections"],"prefix":"10.1093","volume":"70","author":[{"given":"David","family":"Lebeaux","sequence":"first","affiliation":[{"name":"1 \u00a0Institut Pasteur, Genetics of Biofilms Unit, Department of Microbiology, 28 rue du Dr Roux, 75724 Paris cedex 15, France"},{"name":"2 \u00a0Sorbonne Paris Cit\u00e9, AP-HP, H\u00f4pital Necker Enfants Malades, Centre d'Infectiologie Necker-Pasteur and Institut Imagine, Universit\u00e9 Paris Descartes, 149 Rue de S\u00e8vres, 75743 Paris cedex 15, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Leflon-Guibout","sequence":"additional","affiliation":[{"name":"3 \u00a0Service de Microbiologie, H\u00f4pital Beaujon, AP-HP, Clichy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Ghigo","sequence":"additional","affiliation":[{"name":"1 \u00a0Institut Pasteur, Genetics of Biofilms Unit, Department of Microbiology, 28 rue du Dr Roux, 75724 Paris cedex 15, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Beloin","sequence":"additional","affiliation":[{"name":"1 \u00a0Institut Pasteur, Genetics of Biofilms Unit, Department of Microbiology, 28 rue du Dr Roux, 75724 Paris cedex 15, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,2,23]]},"reference":[{"key":"2022020123173200500_DKV044C1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0148607188012002185","article-title":"Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients","volume":"12","author":"Messing","year":"1988","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2022020123173200500_DKV044C2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jac\/dkl103","article-title":"Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study","volume":"57","author":"Fernandez-Hidalgo","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2022020123173200500_DKV044C3","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/jac\/dkl318","article-title":"Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy","volume":"58","author":"Fortun","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2022020123173200500_DKV044C4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1473-3099(13)70266-4","article-title":"Management of infections related to totally implantable venous-access ports: challenges and perspectives","volume":"14","author":"Lebeaux","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2022020123173200500_DKV044C5","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"2022020123173200500_DKV044C6","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/MMBR.00013-14","article-title":"Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics","volume":"78","author":"Lebeaux","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"key":"2022020123173200500_DKV044C7","first-page":"107","article-title":"Multidrug tolerance of biofilms and persister cells","volume":"322","author":"Lewis","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"2022020123173200500_DKV044C8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2022020123173200500_DKV044C9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1054\/clnu.2001.0500","article-title":"Catheter-related infection in patients on home parenteral nutrition: results of a prospective survey","volume":"21","author":"Reimund","year":"2002","journal-title":"Clin Nutr"},{"key":"2022020123173200500_DKV044C10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/jac\/dkh488","article-title":"Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial","volume":"55","author":"Rijnders","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"2022020123173200500_DKV044C11","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1093\/cid\/cir551","article-title":"Effectiveness of antibiotic-lock therapy for long-term catheter-related bacteremia due to Gram-negative bacilli: a prospective observational study","volume":"53","author":"Funalleras","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2022020123173200500_DKV044C12","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1128\/AAC.01606-12","article-title":"Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy","volume":"56","author":"Chauhan","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020123173200500_DKV044C13","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/infdis\/jiu286","article-title":"pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms","volume":"210","author":"Lebeaux","year":"2014","journal-title":"J Infect Dis"},{"key":"2022020123173200500_DKV044C14","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1128\/aem.46.5.1236-1238.1983","article-title":"Influence of a calcium-specific chelant on biofilm removal","volume":"46","author":"Turakhia","year":"1983","journal-title":"Appl Environ Microbiol"},{"key":"2022020123173200500_DKV044C15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1345\/aph.1L145","article-title":"Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections","volume":"43","author":"Bookstaver","year":"2009","journal-title":"Ann Pharmacother"},{"key":"2022020123173200500_DKV044C16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/QCO.0b013e32830634d8","article-title":"The role of chelators in preventing biofilm formation and catheter-related bloodstream infections","volume":"21","author":"Raad","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"2022020123173200500_DKV044C17","doi-asserted-by":"crossref","first-page":"e37281","DOI":"10.1371\/journal.pone.0037281","article-title":"A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections","volume":"7","author":"Chauhan","year":"2012","journal-title":"PLoS One"},{"key":"2022020123173200500_DKV044C18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/MD.0b013e318275ffe1","article-title":"Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature","volume":"91","author":"Lebeaux","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"2022020123173200500_DKV044C19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/649793","article-title":"Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001\u20132007","volume":"31","author":"Hulten","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2022020123173200500_DKV044C20","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1128\/AAC.01538-07","article-title":"Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005\u20132006","volume":"52","author":"Zhanel","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020123173200500_DKV044C21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/JB.186.3.595-600.2004","article-title":"Lysogeny at mid-twentieth century: P1, P2, and other experimental systems","volume":"186","author":"Bertani","year":"2004","journal-title":"J Bacteriol"},{"key":"2022020123173200500_DKV044C22","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically\u2014Eighth Edition: Approved Standard M07-A8","author":"Clinical and Laboratory Standards Institute","year":"2009"},{"key":"2022020123173200500_DKV044C23","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20","author":"Clinical and Laboratory Standards Institute","year":"2010"},{"key":"2022020123173200500_DKV044C24","doi-asserted-by":"crossref","first-page":"e1003144","DOI":"10.1371\/journal.pgen.1003144","article-title":"Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin","volume":"9","author":"Bernier","year":"2013","journal-title":"PLoS Genet"},{"key":"2022020123173200500_DKV044C25","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1128\/AEM.72.3.2064-2069.2006","article-title":"Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm","volume":"72","author":"Banin","year":"2006","journal-title":"Appl Environ Microbiol"},{"key":"2022020123173200500_DKV044C26","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1515\/cclm-2012-0081","article-title":"EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact","volume":"50","author":"Lippi","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"2022020123173200500_DKV044C27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/dkq410","article-title":"High prevalence of the arginine catabolic mobile element in carriage isolates of methicillin-resistant Staphylococcus epidermidis","volume":"66","author":"Barbier","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2022020123173200500_DKV044C28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tim.2008.05.002","article-title":"The role of virulence determinants in community-associated MRSA pathogenesis","volume":"16","author":"Diep","year":"2008","journal-title":"Trends Microbiol"},{"key":"2022020123173200500_DKV044C29","doi-asserted-by":"crossref","first-page":"e7722","DOI":"10.1371\/journal.pone.0007722","article-title":"Genetic diversity of arginine catabolic mobile element in Staphylococcus epidermidis","volume":"4","author":"Miragaia","year":"2009","journal-title":"PLoS One"},{"key":"2022020123173200500_DKV044C30","doi-asserted-by":"crossref","first-page":"e00889","DOI":"10.1128\/mBio.00889-13","article-title":"Emergence of the epidemic methicillin-resistant Staphylococcus aureus strain USA300 coincides with horizontal transfer of the arginine catabolic mobile element and speG-mediated adaptations for survival on skin","volume":"4","author":"Planet","year":"2013","journal-title":"mBio"},{"key":"2022020123173200500_DKV044C31","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1128\/JCM.38.8.2819-2823.2000","article-title":"Nationwide German multicenter study on prevalence of antibiotic resistance in staphylococcal bloodstream isolates and comparative in vitro activities of quinupristin-dalfopristin","volume":"38","author":"von Eiff","year":"2000","journal-title":"J Clin Microbiol"},{"key":"2022020123173200500_DKV044C32","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1128\/AAC.47.10.3145-3148.2003","article-title":"Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections","volume":"47","author":"Curtin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020123173200500_DKV044C33","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/jac\/dkl098","article-title":"In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci","volume":"57","author":"Lee","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2022020123173200500_DKV044C34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jac\/dkp499","article-title":"Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection","volume":"65","author":"Fern\u00e1ndez-Hidalgo","year":"2010","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/70\/6\/1704\/42358457\/jac_70_6_1704.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/70\/6\/1704\/42358457\/jac_70_6_1704.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T23:18:20Z","timestamp":1643757500000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/70\/6\/1704\/730466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,23]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,2,23]]},"published-print":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkv044","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,6]]},"published":{"date-parts":[[2015,2,23]]}}}